Elusive envelope glycoproteins

Credit: © FELIX MÖCKEL" /> Credit: © FELIX MÖCKEL The paper: B. Chen et al., "Structure of an unliganded simian immunodeficiency virus gp120 core," Nature, 433:834-41, 2005. (Cited in 67 papers) The finding: Using X-ray crystallography, researchers at Harvard Medical School, led by Stephen Harrison, determined the structure, at 4 Å resolution, of the un-bound simian immunodeficiency virus envelope glycoprotein-gp120.

Written byy Andrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The paper:

B. Chen et al., "Structure of an unliganded simian immunodeficiency virus gp120 core," Nature, 433:834-41, 2005. (Cited in 67 papers)

The finding:

Using X-ray crystallography, researchers at Harvard Medical School, led by Stephen Harrison, determined the structure, at 4 Å resolution, of the un-bound simian immunodeficiency virus envelope glycoprotein-gp120.

The surprise:

Harrison's team revealed striking conformational differences between gp120 unliganded and in interaction with the CD4 receptor. They also observed small "pocket" features on the protein that "fill up" when CD4 binding occurs-helping to explain why some small-molecule entry inhibitors are therapeutically successful.

The challenge:

The difficulty of growing unliganded SIV and HIV gp120 crystals continues to frustrate researchers, slowing the progress of getting a complete structure of the gp120/41 trimer, or "spike," according to Harrison.

The next step:

Viral therapies already include some small-molecule entry inhibitors that target the gp120-CD4 binding site. However, once the human gp120/41 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies